- Home
- TNGX vs OSUR Comparison
TNGX vs OSUR Comparison
Compare TNGX & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- OSUR
- Stock Information
- Founded
- TNGX 2014
- OSUR 2000
- Country
- TNGX United States
- OSUR United States
- Employees
- TNGX N/A
- OSUR N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- OSUR Medical/Dental Instruments
- Sector
- TNGX Health Care
- OSUR Health Care
- Exchange
- TNGX Nasdaq
- OSUR Nasdaq
- Market Cap
- TNGX 317.4M
- OSUR 289.4M
- IPO Year
- TNGX N/A
- OSUR 1986
- Fundamental
- Price
- TNGX $3.35
- OSUR $3.99
- Analyst Decision
- TNGX Strong Buy
- OSUR Hold
- Analyst Count
- TNGX 8
- OSUR 2
- Target Price
- TNGX $13.14
- OSUR $5.50
- AVG Volume (30 Days)
- TNGX 757.1K
- OSUR 874.4K
- Earning Date
- TNGX 03-17-2025
- OSUR 02-25-2025
- Dividend Yield
- TNGX N/A
- OSUR N/A
- EPS Growth
- TNGX N/A
- OSUR N/A
- EPS
- TNGX N/A
- OSUR 0.15
- Revenue
- TNGX $43,383,000.00
- OSUR $224,263,000.00
- Revenue This Year
- TNGX $27.73
- OSUR N/A
- Revenue Next Year
- TNGX N/A
- OSUR N/A
- P/E Ratio
- TNGX N/A
- OSUR $26.41
- Revenue Growth
- TNGX 15.67
- OSUR N/A
- 52 Week Low
- TNGX $2.59
- OSUR $3.52
- 52 Week High
- TNGX $12.89
- OSUR $8.04
- Technical
- Relative Strength Index (RSI)
- TNGX 58.01
- OSUR 55.51
- Support Level
- TNGX $2.82
- OSUR $3.87
- Resistance Level
- TNGX $3.20
- OSUR $4.09
- Average True Range (ATR)
- TNGX 0.20
- OSUR 0.15
- MACD
- TNGX 0.05
- OSUR 0.02
- Stochastic Oscillator
- TNGX 97.40
- OSUR 70.00
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.